Half-time controls

Half-time review: Sander Busker

2017-09-1910:00 Vindskupan, CCK R8:05Karolinska University Hospital, Solna

STAT3 junction as a target in cancer therapy

Half-time board

PhD Giovanna Zinzalla, Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology
PhD Päivi Östling, SciLifeLab, Karolinska Institutet, Department of Oncology-Pathology
PhD Benjamin Pelcman, Stockholm University, Department of Molecular Bioscience

Supervisors

Professor Dan Grandér, Karolinska Institutet, Department of Oncology-Pathology
PhD Daniel Hägerstrand, Karolinska Institutet, Department of Oncology-Pathology
Associate Professor Katja Pokrovskaja Tamm, Karolinska Institutet, Department of Oncology-Pathology

Welcome!